APA

Brantley E., Patel V., Stinson S. F., Trapani V., Hose C. D., Ciolino H. P., Yeh G. C., Gutkind J. S., Sausville E. A. & Loaiza-Pérez A. I. (20050908). The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells. : Anti-cancer drugs.

Chicago

Brantley Eileen, Patel Vyomesh, Stinson Sherman F, Trapani Valentina, Hose Curtis D, Ciolino Henry P, Yeh Grace C, Gutkind J Silvio, Sausville Edward A and Loaiza-Pérez Andrea I. 20050908. The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells. : Anti-cancer drugs.

Harvard

Brantley E., Patel V., Stinson S. F., Trapani V., Hose C. D., Ciolino H. P., Yeh G. C., Gutkind J. S., Sausville E. A. and Loaiza-Pérez A. I. (20050908). The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells. : Anti-cancer drugs.

MLA

Brantley Eileen, Patel Vyomesh, Stinson Sherman F, Trapani Valentina, Hose Curtis D, Ciolino Henry P, Yeh Grace C, Gutkind J Silvio, Sausville Edward A and Loaiza-Pérez Andrea I. The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells. : Anti-cancer drugs. 20050908.